How Academic Researchers and Policy Experts Use DrugPatentWatch
Books and Research Papers Citing DrugPatentWatch

All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2015 — 4 Books and Research Papers Citing DrugPatentWatch

JB Barslund (2015). Valuation of Novo Nordisk A/S. Copenhagen Business School.
This paper employs DrugPatentWatch data to assess the impact of patent expirations on Novo Nordisk’s market valuation. It demonstrates how the loss of exclusivity for key diabetes medications influences investor perceptions and company performance.

M. Chaudhuri (2015). Impact of Marketing Investments on Firm Value. ProQuest.
Chaudhuri's study utilizes DrugPatentWatch data to analyze how pharmaceutical companies' marketing expenditures affect their stock prices. The research highlights the strategic importance of patent portfolios in sustaining firm value amidst generic competition.

PO Osadebe, EU Odoh, PF Uzor (2015). Oral Anti-Diabetic Agents: Review and Updates. British Journal of Medicine and Medical Research.
This comprehensive review references DrugPatentWatch to examine the patent landscape of oral anti-diabetic agents. It provides insights into the lifecycle of these drugs, from patenting to market entry, and discusses the implications for generic drug development.

VTH Larsen (2015). Valuation of Photocure ASA. NordOpen.
Larsen's valuation of Photocure ASA incorporates DrugPatentWatch data to evaluate the company's intellectual property assets. The analysis underscores the role of patent protection in determining the financial health and market position of biotech firms.

Sign up for DrugPatentWatch Today

Try a free trialSee Plans and Pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.